| Cherie H Johnson, DPM | |
|
3131 Nassau St, Suite #101, Everett, WA 98201-4137 | |
| (425) 339-8888 | |
| (425) 258-6933 |
| Full Name | Cherie H Johnson |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 29 Years |
| Location | 3131 Nassau St, Everett, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427024132 | NPI | - | NPPES |
| 5996724 | Other | WA | AETNA U.S. HEALTHCARE |
| 120018 | Other | WA | WORKER'S COMPENSATION |
| J01543 | Other | WA | REGENCE BLUESHIELD |
| 1104322 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO00000583 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Washington Medical Ctr | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
The Gatherer Partnership, conceived to develop innovative products that offer physiotherapists accurate and objective data for the management of neuromusculoskeletal conditions, has announced it is part of the respected rehabilitation facilities at The Royal Buckinghamshire Hospital (RBH).
Some patients are genetically prone to such dangerously high levels of cholesterol that no amount of diet, exercise and medications can reduce their cholesterol to safe levels.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation compared to well-controlled warfarin without increasing the risk of major bleeding.
It's generally accepted health advice that adults of all ages should sit less, move more, and engage in regular exercise to feel better and reduce the risk of chronic diseases.
› Verified 7 days ago
| Provider Name | The Association Of University Physicians |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
The Gatherer Partnership, conceived to develop innovative products that offer physiotherapists accurate and objective data for the management of neuromusculoskeletal conditions, has announced it is part of the respected rehabilitation facilities at The Royal Buckinghamshire Hospital (RBH).
Some patients are genetically prone to such dangerously high levels of cholesterol that no amount of diet, exercise and medications can reduce their cholesterol to safe levels.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation compared to well-controlled warfarin without increasing the risk of major bleeding.
It's generally accepted health advice that adults of all ages should sit less, move more, and engage in regular exercise to feel better and reduce the risk of chronic diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cherie H Johnson, DPM 3131 Nassau St, Suite #101, Everett, WA 98201-4137 Ph: (425) 339-8888 | Cherie H Johnson, DPM 3131 Nassau St, Suite #101, Everett, WA 98201-4137 Ph: (425) 339-8888 |
News Archive
The Gatherer Partnership, conceived to develop innovative products that offer physiotherapists accurate and objective data for the management of neuromusculoskeletal conditions, has announced it is part of the respected rehabilitation facilities at The Royal Buckinghamshire Hospital (RBH).
Some patients are genetically prone to such dangerously high levels of cholesterol that no amount of diet, exercise and medications can reduce their cholesterol to safe levels.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation compared to well-controlled warfarin without increasing the risk of major bleeding.
It's generally accepted health advice that adults of all ages should sit less, move more, and engage in regular exercise to feel better and reduce the risk of chronic diseases.
› Verified 7 days ago
Jeffrey C Christensen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1823 37th St Ste A, Everett, WA 98201 Phone: 425-339-8888 Fax: 425-258-6933 | |
Everett Foot Clinic Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 3401 Rucker Ave, Everett, WA 98201 Phone: 425-259-3757 Fax: 425-259-6565 | |
Dr. Sean S Laghaeian, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5407 Fax: 425-339-4207 | |
Kevin L Morris, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3202 Colby Ave, Suite E, Everett, WA 98201 Phone: 425-259-0855 | |
Dr. Jessica Lea Lund, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5407 Fax: 425-339-4207 | |
Dr. Bryan Leonard Berghout, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 10821 19th Ave Se, Everett, WA 98208 Phone: 425-337-7000 Fax: 425-338-2408 | |
Dr. Timothy Jarrod Mccord, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3401 Rucker Ave, Everett, WA 98201 Phone: 425-259-3757 Fax: 425-259-6565 |